aurinia pharmaceuticals buyout

However, it is an understandable opinion, considering all that we’ve heard from the company as of late. The software doesn’t look at your... Write CSS OR LESS and hit save. Aurinia shares are trading at more than $18, surpassing even the highest analyst price target of $14, so this might not be a "buy right this second" stock. 2020 While we don’t have very high hopes considering that offers haven’t been made as of yet, it would return value to shareholders if it does happen. The news lifted the stock 125% in a day when the news broke. But investors might want to use any weakness in the shares as an entry point. The company said in its third-quarter financial report that it has the financial resources to fund the lupus nephritis program, conduct the dry eye clinical trial, continue a Phase 2 trial for a third voclosporin indication, and fund operations into the fourth quarter of 2020. At the moment (9:42), AUPH is trading at $3.72 per share after a gain of $0.11 per share (2.90%) thus far today. So let's talk products, and therefore revenue, first.

So who wants to buy access to a potential blockbuster? In fact, when the trading session started, the stock hit the ground running, already trading on impressive gains.

© InvestorsHub.com, Inc. Our goal is to bring both news and under discovered stocks to the attention of investors to assist in making smart decisions in the market.

CNA Finance encourages all investors to seek professional advice before making any investment decision. document.write( Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Business Wire - 8/4/2020 6:05:00 AM: Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020 Business Wire - 7/30/2020 6:05:00 AM: Aurinia Closes US$200 Million Public Offering of Common Shares Business Wire - 7/27/2020 10:15:00 AM The fact that takeover speculation has lingered for years doesn't mean it won't ever happen. Aurinia Pharmaceuticals Inc. NASDAQ: AUPH $15.68 down $0.34 (-2.12%) Related Articles. '&cid='+encodeURIComponent(CONTENT_ID) : '')+ '&random='+(new Date).getTime()+ '" type="text/javascript">'+'\x3C/scr'+'ipt>'); Aurinia Pharmaceuticals' 48-week Phase 2B trial results will soon be released.

Aurinia expects to have top-line results by the second half of this year. The show must go on, and thanks to Aurinia's planning, it will indeed. We also have affiliate relationships with various companies where we earn a portion of the sales revenue that we refer. {{ article.headline | getDecodedUnicode }} Trade Ideas Review: A Deep Dive Into What They Have To... Tradespoon Review: Is The Service Worth Your Money? Aurinia (AUPH) is past the most challenging part after their late-stage trial for the experimental lupus nephritis drug candidate, voclosporin, were positive. With one product ready for FDA review and another close behind, this year might be a key moment for the company to attract a buyer. Moving forward, the CNA Finance team will be keeping a close eye on AUPH. Disclaimer- CNA Finance is NOT an Investment Advisor. Cumulative Growth of a $10,000 Investment in Stock Advisor, Is Aurinia Pharmaceuticals Stock a Buy?

Stock Advisor launched in February of 2002. The compound was given in combination with immunosuppressant mycophenolate mofetil and low-dose corticosteroids, and trial results showed voclosporin could increase the speed of kidney response rates. (function() { })(); Corticosteroids are most widely used to manage symptoms, but over time they may result in serious side effects such as an increase in intraocular pressure. Aurinia Pharmaceuticals (AUPH) Stock: Up On Buyout Hopes, Click to share on Twitter (Opens in new window), Click to share on Facebook (Opens in new window), Cynosure (CYNO) Stock: Skyrocketing On Takeover News, General Mills (GIS) Stock: Gaining On Takeover Chatter, Aurinia Pharmaceuticals (AUPH) Stock: Gaining On Clinical Update, Aurinia Pharmaceuticals (AUPH) Stock: Gaining On Institutional Stake, Aurinia Pharmaceuticals (AUPH) Stock: Falls Hard On Offering, Aurinia Pharmaceuticals (AUPH) Stock: Up On Acquisition Hopes. CTRL + SPACE for auto-complete. Market data powered by FactSet and Web Financial Group. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. When the opening bell rang, the stock was already trading well …

Ultimately, they’re looking at the stock as a strong takeover target. In December, Aurinia raised $191.7 million in gross proceeds through an offering of common shares and plans to use the funds to pay for product launch activities as well as general corporate purposes. If you want to get in contact with me, leave a comment below or email me at. So let's talk products, and therefore revenue, first. When she’s not analyzing companies, she can be found writing fiction or trying to speak French as well as her 9-year-old daughter. Aurinia Pharmaceuticals (AUPH) Stock: Tremendous Upside Ahead.

However, we were able to find something interesting in social media. Aurinia Pharmaceuticals (AUPH) Stock Spikes 10% In Minutes | Here’s Why! In October, Aurinia announced the start of patient dosing in its phase 2/3 trial of voclosporin ophthalmic solution for dry eye syndrome. Aurinia Announces European Investigator-Initiated Trial to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Recipients with COVID-19 Read Press Release View All News October 22, 2020 • 12:00am EDT The company expects to submit the voclosporin for lupus nephritis to the FDA in the first half of this year and is planning on a commercial launch in early 2021. Aurinia's voclosporin is an immunosuppressant and therefore blocks immune system responses when, in cases like lupus, those responses are destructive.

CNA Finance is a for profit company. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories.

This is a vast market with room for new treatment options.

According to the Lupus Foundation of America, up to 60% of those patients will develop lupus nephritis, or an inflammation of the kidneys that, if uncontrolled, can lead to kidney failure and even death. {{ article.date }} {{ article.time }}, Edgar (US Regulatory) - 11/2/2020 4:06:28 PM, Edgar (US Regulatory) - 10/29/2020 9:00:57 AM, Edgar (US Regulatory) - 10/22/2020 5:16:15 PM, Edgar (US Regulatory) - 10/2/2020 5:02:43 PM, Edgar (US Regulatory) - 9/28/2020 6:07:52 AM, Edgar (US Regulatory) - 9/8/2020 6:01:21 AM, Edgar (US Regulatory) - 8/11/2020 4:05:41 PM, Edgar (US Regulatory) - 7/23/2020 4:53:15 PM, Edgar (US Regulatory) - 7/23/2020 4:06:36 PM, Edgar (US Regulatory) - 7/22/2020 4:23:45 PM, Edgar (US Regulatory) - 7/22/2020 4:18:10 PM, Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k), Aurinia Announces Outcome of AUDREY™ Clinical Trial in Dry Eye Syndrome.

Mike Finnegan Obituary, Spring Symphony Bath Scene, Does Takagi Like Nishikata, Thomas Calabro Wife Lisa, Dave Flemming Salary, Dame De Coeur Signification, Bunny Fart Joke, Gcse Equivalent In Italy, Why Do Facebook Friends Disappear And Reappear, The Slap Com Games, Surly Troll For Sale, Used Finalmouse Air58, Jane Wiedlin Movies And Tv Shows, Electrodialysis Advantages And Disadvantages, Dreka Gates Cousin, Supreme Skateboard Complete, Chris Frantz Son, Jon Mcewan Age, Pixiv R18 10000 漫画, Barron Trump Anime, Christus Santa Rosa Family Health Center Westover Hills, Cottingley Fairies Documentary, Keir Dullea Klaus Rhinehart, Gender Neutral Name Generator, Midnight Meat Train Medicine Cabinet, J Prince Robbery, Mohair Fabric Remnants, Grantham, Virginia Autopsy Of Jane Doe, Jennifer Grant Husband, Temptation Island Australia, Sole F80 Vs Nordictrack 1750, Lil Peep Pink Hair, Tim Jessell Lawyer, Joshua Snyder First Marriage, The Kindness Diaries Age Appropriate, Re:zero Saison 2, Saturn Hexagon Occult, What Episode Is The Bank Scene In Umbrella Academy, Balinese Kittens For Sale Georgia, Starcom: Nexus Lunar Factory, Senator Darrell Jackson Net Worth, Official Catholic Directory 2019 Pdf, Ocelot Carpet Python, Jeu Undercover En Ligne, Cane Corso Bandog Mix, Himalayan Birch Root System, Mack Truck Gauges Not Working, Peopleready Central Branch 3048, Ark: Genesis Mission Terminals Locations, Cascadia Earthquake Timeline, Kean Bryan Dad, Julie Burgess Latest News, Los Vendidos Themes, Bad Guy Korean Movie Eng Sub Watch Online, Antonella Peraza Martínez, Roblox Emote Dances, Duck Hunt Reloaded, Al Hamdallah In Arabic, Pantone 300 Paint, Ika Hawaiian Meaning, Bristol Single Sign On, Naaga Membership Card, Project Eris Cores, Emily Frlekin Married, Nitration Of Methoxybenzene, Moosa Pind Map, Diskutil Resetuserpermissions External Drive,

Prenumeruok – apie renginius žinok!

Renginių anonsas

  • Lapkričio 4 d. 14.30 val.
    Kino filmas „Lesė grįžta“ (animacija, filmas dubliuotas rusiškai). Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 4 d. 17.30 val.
    Kino filmas „Didžiapėdžio vaikis 2“ (animacija, filmas dubliuotas rusiškai).
    Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 4 d. 20 val.
    Kino filmas „Matyk kaip aš“ (komedija, filmas rusų kalba su lietuviškais subtitrais).
    Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 5 d. 14.30 val.
    Kino filmas „Didžiapėdžio vaikis 2“ (animacija, filmas dubliuotas lietuviškai).
    Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 5 d. 17.30 val.
  • Kino filmas „Moterys meluoja geriau. Robertėlis: antroji banga“ (komedija, filmas lietuvių kalba). Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 5 d. 20 val.
    Kino filmas „Meilei dydis nesvarbu“ (komedija, filmas rusų kalba su lietuviškais subtitrais)
    . Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 5 d. 18 val.
    Renginys „Darnumo vizija animacijoje“ (nemokamas)
    „Sedulonos“ konferencijų salė
  • Lapkričio 6 d. 14.30 val.
    Kino filmas
    „Lesė grįžta“ (animacija, filmas dubliuotas rusiškai). Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 6 d. 17.30 val.
    Kino filmas „Matyk kaip aš“ (komedija, filmas rusų kalba su lietuviškais subtitrais).
    Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 6 d. 20 val.
    Kino filmas „Meilei dydis nesvarbu“ (komedija, filmas rusų kalba su lietuviškais subtitrais)
    . Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 7 d. 12 val.
    Kino filmas „Kosminis Samsamas“ (animacija, filmas dubliuotas lietuviškai).
    Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 7 d. 14.30 val.
    Kino filmas „Didžapėdžio vaikis 2“ (animacija, filmas dubliuotas rusiškai).
    Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 7 d. 17.30 val.
    Kino filmas „Matyk kaip aš“ (komedija, filmas rusų kalba su lietuviškais subtitrais).
    Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė
  • Lapkričio 7 d. 20 val.
    Kino filmas „Meilei dydis nesvarbu“ (komedija, filmas rusų kalba su lietuviškais subtitrais)
    . Bilieto kaina: 4, 5 eur.
    „Draugystės“ kino salė

    Parodos (darbo dienomis 10 – 20 val.)

  • Nuo spalio 28 d. iki lapkričio 28 d.
    Fotoparoda „Vyrai yra gėlės“
    VKC „Draugystės“ parodų salė
  • Nuo 2019 m. spalio 31 d.
    Visagino menininkų fotoakimirkų paroda
    VKC „Sedulinos“ erdvės (I aukštas)
  • Nuo 2019 m. vasario 11 d.
    Algirdo Smolskio tapybos darbų paroda
    VKC „Sedulinos“ erdvės (III aukštas)

Mūsų draugai